← Leaderboards
Francisco J Villarreal
Va San Diego Healthcare System
$8,393,260
Attributed
$10,814,762
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,814,762 · 10
VA$0 · 2
By mechanism
R01$6,580,341 · 4
K12$2,820,785 · 1
R21$711,723 · 2
R24$459,413 · 1
R56$232,500 · 1
R13$10,000 · 1
Top collaborators
- Robert Roy Henry5 shared
- Joann Trejo4 shared
Others in their field
Top investigators on “Heart Failure”
- Judith S Hochman · New York University School Of Medicine$120,321,606
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$51,947,333
- Lisa P Jacobson · Johns Hopkins University$45,397,923
- Walter N Kernan · Yale University$42,197,025
- Dalane W Kitzman · Wake Forest University$40,701,149
- David Couper · Univ Of North Carolina Chapel Hill$37,959,091
Research focus
Heart FailureCollagenLinkProteinsReportingAnimalsStructureIn VivoResponseFutureCardiacMyocardialFibrosisAreaHeartTissuesPlayCellsAdverse EffectsIn VitroInflammationPreparationNon-Insulin-Dependent Diabetes MellitusMediating
Grant awards (37)
Beneficial Effects of FPR Agonists on an Animal Model of Early Stage Heart Failure with Preserved Ejection Fraction$0
I01 · FY2025 · VA · contact PI
Beneficial Effects of FPR Agonists on an Animal Model of Early Stage Heart Failure with Preserved Ejection Fraction$0
I01 · FY2024 · VA · contact PI
Beneficial Effects of FPR Agonists on an Animal Model of Early Stage Heart Failure with Preserved Ejection Fraction$0
I01 · FY2023 · VA · contact PI
Excess O-GlcNAc modification of proteins and myocardial fibrosis$0
I01 · FY2021 · VA · contact PI
Excess O-GlcNAc modification of proteins and myocardial fibrosis$0
I01 · FY2020 · VA · contact PI
Excess O-GlcNAc modification of proteins and myocardial fibrosis$0
I01 · FY2019 · VA · contact PI
Excess O-GlcNAc modification of proteins and myocardial fibrosis$0
I01 · FY2018 · VA · contact PI
Epicatechin and derivatives to preserve muscle structure function in diabetes$344,875
R01 · FY2017 · DK · contact PI
Epicatechin Treatment for Sarcopenia$232,500
R56 · FY2017 · AG · contact PI
Epicatechin and derivatives to preserve muscle structure function in diabetes$344,875
R01 · FY2016 · DK · contact PI
San Diego IRACDA: Professors for the Future$935,041
K12 · FY2015 · GM
Epicatechin and derivatives to preserve muscle structure function in diabetes$344,875
R01 · FY2015 · DK · contact PI
Epicatechin treatment for sarcopenia$232,500
R21 · FY2015 · AG · contact PI
San Diego IRACDA: Professors for the Future$935,041
K12 · FY2014 · GM
Epicatechin and derivatives to preserve muscle structure function in diabetes$344,875
R01 · FY2014 · DK · contact PI
San Diego IRACDA: Professors for the Future$13,662
K12 · FY2014 · GM
San Diego IRACDA: Professors for the Future$937,041
K12 · FY2013 · GM
Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin$642,719
R01 · FY2013 · AT
Targeting cellular bioenergetics for the prevention and treatment of diabetes$459,413
R24 · FY2011 · DK · contact PI
Molecular biology and mechanics of the cardiac interstitium$385,968
R01 · FY2011 · HL · contact PI
Molecular biology and mechanics of the cardiac interstitium$410,094
R01 · FY2010 · HL · contact PI
Molecular biology and mechanics of the cardiac interstitium$385,985
R01 · FY2009 · HL · contact PI
Effects of Cocoa Flavonols on Myocardial Infarction Size and Post-Injury Injury$193,125
R21 · FY2009 · AT · contact PI
Effects of Cocoa Flavonols on Myocardial Infarction Size and Post-Injury Injury$54,348
R21 · FY2009 · AT · contact PI
Molecular biology and mechanics of the cardiac interstitium$35,308
R01 · FY2009 · HL · contact PI
Molecular biology and mechanics of the cardiac interstitium$399,613
R01 · FY2008 · HL · contact PI
Effects of Cocoa Flavonols on Myocardial Infarction Size and Post-Injury Injury$231,750
R21 · FY2008 · AT · contact PI
Molecular biology and mechanics of cardiac interstitium$380,000
R01 · FY2005 · HL
Adenosine Mediated Modulation of Cardiac Fibrosis$342,000
R01 · FY2005 · HL
Molecular biology and mechanics of cardiac interstitium$380,000
R01 · FY2004 · HL
Adenosine Mediated Modulation of Cardiac Fibrosis$342,000
R01 · FY2004 · HL
Molecular biology and mechanics of cardiac interstitium$53,154
R01 · FY2004 · HL
26th Annual Meeting of the North Am. Section of the ISHR$10,000
R13 · FY2004 · HL
Molecular biology and mechanics of cardiac interstitium$380,000
R01 · FY2003 · HL
Adenosine Mediated Modulation of Cardiac Fibrosis$342,000
R01 · FY2003 · HL
Molecular biology and mechanics of cardiac interstitium$380,000
R01 · FY2002 · HL
Adenosine Mediated Modulation of Cardiac Fibrosis$342,000
R01 · FY2002 · HL